Details for: SMC3

Gene ID: 9126

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: SMC3

Ensembl ID: ENSG00000108055

Description: structural maintenance of chromosomes 3

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 34.55
    rCSI 31.2%
    PRS 20.9
  • fraction A pre-pro B cell CL0002045
    CSI 31.73
    rCSI 36.33%
    PRS 45.44
  • common dendritic progenitor CL0001029
    CSI 29.24
    rCSI 36.7%
    PRS 29.88
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 26.66
    rCSI 30.79%
    PRS 19.89
  • pancreatic ductal cell CL0002079
    CSI 23.58
    rCSI 45.85%
    PRS 23.6
  • common myeloid progenitor CL0000049
    CSI 23.18
    rCSI 18.75%
    PRS 23.19
  • CD4-positive helper T cell CL0000492
    CSI 22.93
    rCSI 17.34%
    PRS 31.66
  • lung secretory cell CL1000272
    CSI 20.96
    rCSI 51.89%
    PRS 21.29
  • large pre-B-II cell CL0000957
    CSI 20.21
    rCSI 57.7%
    PRS 38.08
  • fallopian tube secretory epithelial cell CL4030006
    CSI 19.27
    rCSI 18.55%
    PRS 23.79
  • pro-B cell CL0000826
    CSI 17.06
    rCSI 14.13%
    PRS 23.4
  • forebrain radial glial cell CL0013000
    CSI 15.6
    rCSI 50.07%
    PRS 31.95
  • group 3 innate lymphoid cell CL0001071
    CSI 13.97
    rCSI 10.5%
    PRS 24.69
  • muscle cell CL0000187
    CSI 13.31
    rCSI 27.33%
    PRS 47.1
  • radial glial cell CL0000681
    CSI 12.81
    rCSI 17.8%
    PRS 23.26
  • melanocyte CL0000148
    CSI 12.7
    rCSI 9.4%
    PRS 19.76
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 11.75
    rCSI 45.73%
    PRS 37.61
  • granulocyte monocyte progenitor cell CL0000557
    CSI 11.26
    rCSI 9.75%
    PRS 25.96
  • pancreatic A cell CL0000171
    CSI 11.23
    rCSI 11.77%
    PRS 24.38
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 11.06
    rCSI 57.09%
    PRS 44
  • cerebral cortex endothelial cell CL1001602
    CSI 11.01
    rCSI 19.04%
    PRS 17.53
  • neural crest cell CL0011012
    CSI 11
    rCSI 8.69%
    PRS 15.76
  • enteroendocrine cell CL0000164
    CSI 10.92
    rCSI 14.92%
    PRS 25.53
  • mesodermal cell CL0000222
    CSI 10.55
    rCSI 12.67%
    PRS 22.36
  • mesangial cell CL0000650
    CSI 10.29
    rCSI 41.92%
    PRS 32.57
  • neural progenitor cell CL0011020
    CSI 9.96
    rCSI 43.84%
    PRS 21.07
  • blood vessel endothelial cell CL0000071
    CSI 9.5
    rCSI 19.71%
    PRS 22.91
  • naive T cell CL0000898
    CSI 9.36
    rCSI 6.52%
    PRS 32.55
  • cardiac neuron CL0010022
    CSI 9.23
    rCSI 29.54%
    PRS 18.78
  • VIP GABAergic cortical interneuron CL4023016
    CSI 8.59
    rCSI 10.26%
    PRS 13.47
  • thymocyte CL0000893
    CSI 8.5
    rCSI 30.23%
    PRS 63.42
  • tracheobronchial smooth muscle cell CL0019019
    CSI 8.39
    rCSI 14.8%
    PRS 29.71
  • primitive red blood cell CL0002355
    CSI 8.06
    rCSI 43.47%
    PRS 38.42
  • cerebral cortex GABAergic interneuron CL0010011
    CSI 7.62
    rCSI 22.49%
    PRS 27
  • renal alpha-intercalated cell CL0005011
    CSI 7.56
    rCSI 10.11%
    PRS 29.49
  • epithelial cell of lower respiratory tract CL0002632
    CSI 7.5
    rCSI 5.81%
    PRS 22.16
  • retina horizontal cell CL0000745
    CSI 7.25
    rCSI 11.06%
    PRS 21.18
  • transit amplifying cell of colon CL0009011
    CSI 7.2
    rCSI 8.46%
    PRS 26.32
  • pulmonary alveolar type 1 cell CL0002062
    CSI 7.19
    rCSI 41.46%
    PRS 28.7
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 7.13
    rCSI 9.71%
    PRS 51.5
  • peripheral nervous system neuron CL2000032
    CSI 7.12
    rCSI 9.71%
    PRS 20.12
  • hematopoietic stem cell CL0000037
    CSI 6.99
    rCSI 4.65%
    PRS 27.56
  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 6.93
    rCSI 5.2%
    PRS 59.05
  • IgA plasma cell CL0000987
    CSI 6.92
    rCSI 7.09%
    PRS 41.16
  • renal beta-intercalated cell CL0002201
    CSI 6.89
    rCSI 16.43%
    PRS 25.94
  • perivascular cell CL4033054
    CSI 6.86
    rCSI 9.37%
    PRS 25.96
  • T follicular helper cell CL0002038
    CSI 6.7
    rCSI 5.01%
    PRS 36.12
  • keratinocyte CL0000312
    CSI 6.61
    rCSI 5.54%
    PRS 27.22
  • early lymphoid progenitor CL0000936
    CSI 6.51
    rCSI 5.72%
    PRS 26.63
  • ciliated epithelial cell CL0000067
    CSI 6.49
    rCSI 5.71%
    PRS 16.71
  • transit amplifying cell of small intestine CL0009012
    CSI 6.46
    rCSI 28.37%
    PRS 41.47
  • podocyte CL0000653
    CSI 6.46
    rCSI 28.7%
    PRS 22.38
  • promonocyte CL0000559
    CSI 6.24
    rCSI 10.68%
    PRS 31.17
  • double negative thymocyte CL0002489
    CSI 6.01
    rCSI 4.18%
    PRS 27.83
  • platelet CL0000233
    CSI 5.99
    rCSI 24.87%
    PRS 39.19
  • ciliated cell CL0000064
    CSI 5.94
    rCSI 9.62%
    PRS 23.07
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 5.91
    rCSI 9.21%
    PRS 50.54
  • intestine goblet cell CL0019031
    CSI 5.9
    rCSI 5.24%
    PRS 23.17
  • central nervous system neuron CL2000029
    CSI 5.83
    rCSI 42.86%
    PRS 14.08
  • OFF-bipolar cell CL0000750
    CSI 5.69
    rCSI 7.78%
    PRS 34.69
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 5.68
    rCSI 7.44%
    PRS 32.88
  • extravillous trophoblast CL0008036
    CSI 5.6
    rCSI 6.93%
    PRS 20.16
  • renal principal cell CL0005009
    CSI 5.41
    rCSI 14.05%
    PRS 29.12
  • regular ventricular cardiac myocyte CL0002131
    CSI 5.39
    rCSI 33.7%
    PRS 17.95
  • precursor B cell CL0000817
    CSI 5.39
    rCSI 4.72%
    PRS 30.42
  • astrocyte of the cerebral cortex CL0002605
    CSI 5.25
    rCSI 11.78%
    PRS 14.27
  • lung pericyte CL0009089
    CSI 5.19
    rCSI 13.7%
    PRS 27.45
  • Kupffer cell CL0000091
    CSI 4.79
    rCSI 10.96%
    PRS 22.42
  • stem cell CL0000034
    CSI 4.74
    rCSI 4.57%
    PRS 16.78
  • promyelocyte CL0000836
    CSI 4.72
    rCSI 6.81%
    PRS 32.05
  • neural cell CL0002319
    CSI 4.72
    rCSI 17.81%
    PRS 28.5
  • enterocyte CL0000584
    CSI 4.6
    rCSI 7.42%
    PRS 34.36
  • unswitched memory B cell CL0000970
    CSI 4.54
    rCSI 3.82%
    PRS 36.37
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 4.53
    rCSI 5.48%
    PRS 27.87
  • pancreatic PP cell CL0002275
    CSI 4.53
    rCSI 18.03%
    PRS 38.63
  • stromal cell of ovary CL0002132
    CSI 4.5
    rCSI 12.38%
    PRS 37.24
  • mature T cell CL0002419
    CSI 4.46
    rCSI 3.47%
    PRS 33.86
  • lung interstitial macrophage CL4033043
    CSI 4.38
    rCSI 9.84%
    PRS 43.87
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 4.22
    rCSI 3.9%
    PRS 41.09
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 4.18
    rCSI 4.1%
    PRS 35.67
  • glioblast CL0000030
    CSI 4.14
    rCSI 6.6%
    PRS 19.53
  • pulmonary capillary endothelial cell CL4028001
    CSI 4.11
    rCSI 7.83%
    PRS 35.9
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 4.01
    rCSI 4.86%
    PRS 28.09
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI 3.99
    rCSI 23.51%
    PRS 14.29
  • plasmablast CL0000980
    CSI 3.98
    rCSI 3.13%
    PRS 27.94
  • myeloid leukocyte CL0000766
    CSI 3.98
    rCSI 3.67%
    PRS 24.05
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 3.97
    rCSI 4.05%
    PRS 32.82
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 3.95
    rCSI 6.97%
    PRS 13.5
  • follicular B cell CL0000843
    CSI 3.93
    rCSI 14.27%
    PRS 64.89
  • regulatory T cell CL0000815
    CSI 3.91
    rCSI 4.53%
    PRS 56.86
  • eosinophil CL0000771
    CSI 3.86
    rCSI 25.3%
    PRS 55.29
  • myofibroblast cell CL0000186
    CSI 3.77
    rCSI 5.22%
    PRS 31.6
  • mesenchymal cell CL0008019
    CSI 3.75
    rCSI 9.52%
    PRS 22.88
  • inhibitory interneuron CL0000498
    CSI 3.67
    rCSI 8.48%
    PRS 18.49
  • pancreatic D cell CL0000173
    CSI 3.67
    rCSI 3.61%
    PRS 24.7
  • interstitial cell of Cajal CL0002088
    CSI 3.65
    rCSI 4.65%
    PRS 26.52
  • blood vessel smooth muscle cell CL0019018
    CSI 3.59
    rCSI 29.2%
    PRS 22.46
  • alternatively activated macrophage CL0000890
    CSI 3.58
    rCSI 4.5%
    PRS 35.05
  • retinal cone cell CL0000573
    CSI 3.57
    rCSI 5.75%
    PRS 17.53
  • epithelial cell of lung CL0000082
    CSI 3.53
    rCSI 2.93%
    PRS 21.83
  • neuroendocrine cell CL0000165
    CSI 0.1
    rCSI 0.3%
    PRS 43.4%
  • medium spiny neuron CL1001474
    CSI 0.1
    rCSI 1.1%
    PRS 12.4%
  • cytotoxic T cell CL0000910
    CSI 0.2
    rCSI 0.9%
    PRS 33.9%
  • hair follicular keratinocyte CL2000092
    CSI 0.2
    rCSI 3.5%
    PRS 69.5%
  • enterocyte of epithelium of small intestine CL1000334
    CSI 0.2
    rCSI 3.5%
    PRS 52.7%
  • vein endothelial cell of respiratory system CL4033008
    CSI 0.3
    rCSI 1.7%
    PRS 43.3%
  • paneth cell of colon CL0009009
    CSI 0.3
    rCSI 2.9%
    PRS 54.5%
  • group 2 innate lymphoid cell CL0001069
    CSI 0.3
    rCSI 1.8%
    PRS 66.4%
  • diffuse bipolar 3a cell CL4033029
    CSI 0.4
    rCSI 2.4%
    PRS 24.2%
  • epithelial cell of nephron CL1000449
    CSI 0.4
    rCSI 3.7%
    PRS 72.4%
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI 0.4
    rCSI 1.4%
    PRS 12.8%
  • intestinal crypt stem cell of colon CL0009043
    CSI 0.4
    rCSI 3.1%
    PRS 41.4%
  • macroglial cell CL0000126
    CSI 0.4
    rCSI 1.1%
    PRS 29.1%
  • respiratory goblet cell CL0002370
    CSI 0.4
    rCSI 4.7%
    PRS 43.0%
  • H2 horizontal cell CL0004218
    CSI 0.4
    rCSI 2.2%
    PRS 24.7%
  • luminal epithelial cell of mammary gland CL0002326
    CSI 0.4
    rCSI 0.8%
    PRS 34.9%
  • bronchiolar smooth muscle cell CL4033017
    CSI 0.5
    rCSI 7.0%
    PRS 57.5%
  • Hofbauer cell CL3000001
    CSI 0.5
    rCSI 0.9%
    PRS 29.2%
  • exhausted T cell CL0011025
    CSI 0.6
    rCSI 9.5%
    PRS 66.4%
  • erythroblast CL0000765
    CSI 0.6
    rCSI 1.5%
    PRS 35.3%
  • P/D1 enteroendocrine cell CL0002268
    CSI 0.6
    rCSI 3.1%
    PRS 50.4%
  • eye photoreceptor cell CL0000287
    CSI 0.6
    rCSI 6.5%
    PRS 51.6%
  • intermediate monocyte CL0002393
    CSI 0.6
    rCSI 0.9%
    PRS 23.5%
  • retinal ganglion cell CL0000740
    CSI 0.6
    rCSI 1.3%
    PRS 16.4%
  • germinal center B cell CL0000844
    CSI 0.7
    rCSI 2.0%
    PRS 49.7%
  • squamous epithelial cell CL0000076
    CSI 0.7
    rCSI 1.6%
    PRS 28.3%
  • pancreatic epsilon cell CL0005019
    CSI 0.7
    rCSI 3.1%
    PRS 48.3%
  • megakaryocyte CL0000556
    CSI 0.7
    rCSI 3.0%
    PRS 39.2%
  • transitional stage B cell CL0000818
    CSI 0.7
    rCSI 2.3%
    PRS 56.9%
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 0.7
    rCSI 2.0%
    PRS 29.8%
  • keratocyte CL0002363
    CSI 0.7
    rCSI 1.8%
    PRS 33.3%
  • kidney connecting tubule epithelial cell CL1000768
    CSI 0.8
    rCSI 1.9%
    PRS 17.4%
  • mucus secreting cell CL0000319
    CSI 0.8
    rCSI 1.2%
    PRS 29.4%
  • GABAergic amacrine cell CL4030027
    CSI 0.8
    rCSI 2.7%
    PRS 19.9%
  • small pre-B-II cell CL0000954
    CSI 0.8
    rCSI 0.8%
    PRS 45.5%
  • skeletal muscle satellite cell CL0000594
    CSI 0.8
    rCSI 2.3%
    PRS 60.3%
  • enteroendocrine cell of small intestine CL0009006
    CSI 0.9
    rCSI 1.9%
    PRS 34.4%
  • ventricular cardiac muscle cell CL2000046
    CSI 0.9
    rCSI 3.0%
    PRS 67.8%
  • corneal epithelial cell CL0000575
    CSI 0.9
    rCSI 2.5%
    PRS 39.6%
  • amacrine cell CL0000561
    CSI 0.9
    rCSI 2.6%
    PRS 17.8%
  • glial cell CL0000125
    CSI 0.9
    rCSI 3.5%
    PRS 22.0%
  • type B pancreatic cell CL0000169
    CSI 0.9
    rCSI 2.1%
    PRS 21.2%
  • sncg GABAergic cortical interneuron CL4023015
    CSI 0.9
    rCSI 1.5%
    PRS 14.9%
  • cardiac muscle cell CL0000746
    CSI 0.9
    rCSI 1.3%
    PRS 17.8%
  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 1.0
    rCSI 1.6%
    PRS 13.7%
  • paneth cell of epithelium of small intestine CL1000343
    CSI 1.0
    rCSI 2.7%
    PRS 35.4%
  • duct epithelial cell CL0000068
    CSI 1.0
    rCSI 1.4%
    PRS 24.4%
  • pancreatic acinar cell CL0002064
    CSI 1.0
    rCSI 1.3%
    PRS 25.2%
  • lung endothelial cell CL1001567
    CSI 1.0
    rCSI 2.3%
    PRS 50.8%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 1.0
    rCSI 2.0%
    PRS 38.3%
  • class switched memory B cell CL0000972
    CSI 1.0
    rCSI 0.8%
    PRS 38.4%
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 1.0
    rCSI 3.9%
    PRS 14.1%
  • dendritic cell, human CL0001056
    CSI 1.1
    rCSI 1.6%
    PRS 27.7%
  • indirect pathway medium spiny neuron CL4023029
    CSI 1.1
    rCSI 25.7%
    PRS 13.1%
  • megakaryocyte progenitor cell CL0000553
    CSI 1.1
    rCSI 19.6%
    PRS 61.0%
  • respiratory basal cell CL0002633
    CSI 1.1
    rCSI 1.1%
    PRS 27.2%
  • retinal rod cell CL0000604
    CSI 1.1
    rCSI 2.0%
    PRS 22.4%
  • pre-conventional dendritic cell CL0002010
    CSI 1.1
    rCSI 14.9%
    PRS 61.6%
  • pulmonary artery endothelial cell CL1001568
    CSI 1.1
    rCSI 1.5%
    PRS 34.5%
  • mature alpha-beta T cell CL0000791
    CSI 1.1
    rCSI 4.1%
    PRS 39.3%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 1.1
    rCSI 1.4%
    PRS 39.7%
  • granulocyte CL0000094
    CSI 1.2
    rCSI 1.8%
    PRS 29.9%
  • acinar cell CL0000622
    CSI 1.2
    rCSI 1.7%
    PRS 30.1%
  • colon goblet cell CL0009039
    CSI 1.2
    rCSI 2.8%
    PRS 33.9%
  • midbrain dopaminergic neuron CL2000097
    CSI 1.2
    rCSI 7.5%
    PRS 34.5%
  • small intestine goblet cell CL1000495
    CSI 1.2
    rCSI 2.6%
    PRS 30.5%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 1.2
    rCSI 2.8%
    PRS 36.3%
  • transit amplifying cell CL0009010
    CSI 1.2
    rCSI 1.8%
    PRS 36.8%
  • innate lymphoid cell CL0001065
    CSI 1.2
    rCSI 2.4%
    PRS 33.8%
  • memory T cell CL0000813
    CSI 1.2
    rCSI 2.3%
    PRS 50.8%
  • foveolar cell of stomach CL0002179
    CSI 1.2
    rCSI 2.6%
    PRS 36.1%
  • erythroid progenitor cell CL0000038
    CSI 1.2
    rCSI 6.9%
    PRS 33.8%
  • Cajal-Retzius cell CL0000695
    CSI 1.2
    rCSI 9.5%
    PRS 43.5%
  • conjunctival epithelial cell CL1000432
    CSI 1.2
    rCSI 1.9%
    PRS 23.2%
  • hepatocyte CL0000182
    CSI 1.2
    rCSI 2.2%
    PRS 21.2%
  • paneth cell CL0000510
    CSI 1.3
    rCSI 1.9%
    PRS 35.7%
  • Bergmann glial cell CL0000644
    CSI 1.3
    rCSI 1.7%
    PRS 22.6%
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 1.3
    rCSI 1.7%
    PRS 43.8%
  • helper T cell CL0000912
    CSI 1.3
    rCSI 1.8%
    PRS 32.2%
  • club cell CL0000158
    CSI 1.3
    rCSI 1.9%
    PRS 26.0%
  • GABAergic neuron CL0000617
    CSI 1.3
    rCSI 4.5%
    PRS 16.6%
  • direct pathway medium spiny neuron CL4023026
    CSI 1.4
    rCSI 33.0%
    PRS 12.2%
  • placental villous trophoblast CL2000060
    CSI 1.4
    rCSI 2.2%
    PRS 21.5%
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 1.4
    rCSI 3.5%
    PRS 13.4%
  • tendon cell CL0000388
    CSI 1.5
    rCSI 3.8%
    PRS 54.1%
  • sst GABAergic cortical interneuron CL4023017
    CSI 1.5
    rCSI 1.9%
    PRS 14.2%
  • rod bipolar cell CL0000751
    CSI 1.5
    rCSI 2.7%
    PRS 19.0%
  • basophil mast progenitor cell CL0002028
    CSI 1.5
    rCSI 8.0%
    PRS 68.7%
  • alveolar macrophage CL0000583
    CSI 1.5
    rCSI 2.5%
    PRS 27.2%
  • basophil CL0000767
    CSI 1.6
    rCSI 3.3%
    PRS 44.8%
  • microcirculation associated smooth muscle cell CL0008035
    CSI 1.6
    rCSI 4.6%
    PRS 25.8%
  • mucous neck cell CL0000651
    CSI 1.6
    rCSI 2.3%
    PRS 35.9%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 1.7
    rCSI 1.1%
    PRS 28.6%
  • ciliated columnar cell of tracheobronchial tree CL0002145
    CSI 1.7
    rCSI 3.8%
    PRS 23.6%
  • retinal pigment epithelial cell CL0002586
    CSI 1.7
    rCSI 3.3%
    PRS 24.0%
  • ionocyte CL0005006
    CSI 1.7
    rCSI 1.8%
    PRS 21.2%
  • progenitor cell CL0011026
    CSI 1.7
    rCSI 3.6%
    PRS 34.0%
  • bronchus fibroblast of lung CL2000093
    CSI 1.7
    rCSI 1.4%
    PRS 24.1%
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 1.7
    rCSI 1.3%
    PRS 21.5%
  • retinal blood vessel endothelial cell CL0002585
    CSI 1.8
    rCSI 2.8%
    PRS 25.2%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [SMC3](/details-gene/9126) (Structural Maintenance of Chromosomes 3) is a protein-coding gene located on chromosome 10q25.2. It encodes a core subunit of the cohesin complex, a ring-shaped protein assembly essential for sister chromatid cohesion, DNA repair, and the regulation of gene expression. This fundamental role in cell division and genome integrity is reflected in its high expression across a wide range of highly proliferative cell types. **Overall**, [SMC3](/details-gene/9126) shows significant expression in various progenitor populations, including hematopoietic cells like [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) and [fraction A pre-pro B cell](/details-cell/CL0002045), as well as in developmental contexts involving [neuroblast (sensu Nematoda and Protostomia)](/details-cell/CL0000338) and [radial glial cell](/details-cell/CL0000681), underscoring its indispensable function in organismal development and tissue maintenance. ## Cellular Roles and Expression Landscape The expression profile of [SMC3](/details-gene/9126) highlights its universal importance in actively dividing cells. The gene's significance is highest in progenitor cells responsible for generating diverse lineages. * **Hematopoietic Progenitors:** [SMC3](/details-gene/9126) is a top marker in multiple hematopoietic stem and progenitor populations. This includes [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) (CSI: 34.55), [fraction A pre-pro B cell](/details-cell/CL0002045) (CSI: 31.73), [common dendritic progenitor](/details-cell/CL0001029) (CSI: 29.24), and [common myeloid progenitor](/details-cell/CL0000049) (CSI: 23.18). This pattern suggests that [SMC3](/details-gene/9126) is a crucial workhorse protein required for the rapid proliferation and differentiation that characterizes hematopoiesis. * **Proliferative and Developmental Tissues:** Beyond the hematopoietic system, [SMC3](/details-gene/9126) is significantly expressed in other mitotically active cells. Its high CSI in [neuroblast (sensu Nematoda and Protostomia)](/details-cell/CL0000338) and various glial progenitors indicates a key role in nervous system development. Furthermore, its expression in secretory cells from the pancreas and lungs, such as [pancreatic ductal cell](/details-cell/CL0002079) and [lung secretory cell](/details-cell/CL1000272), points to its function in the maintenance of epithelial tissues with high turnover rates. The broad but specific expression pattern in progenitor and rapidly dividing cells, rather than terminally differentiated ones, reinforces the primary role of [SMC3](/details-gene/9126) as a central component of the cell division machinery. ## Pathways and Molecular Function Functional annotations for [SMC3](/details-gene/9126) confirm its central role in chromosome dynamics and cell cycle control. As a key component of the [cohesin complex](/details-go/GO:0008278), its functions are deeply integrated into processes that ensure genomic stability. * **Cell Cycle and Mitosis:** [SMC3](/details-gene/9126) is integral to the [Cell cycle](/details-reactome/R-HSA-1640170), particularly the processes of [Sister chromatid cohesion](/details-go/GO:0007062) and its establishment during [S phase](/details-reactome/R-HSA-69242) and resolution during [M phase](/details-reactome/R-HSA-68886). The acetylation of [SMC3](/details-gene/9126) is a critical step for establishing cohesion during S phase ([Link](https://doi.org/10.1016/j.molcel.2008.06.006)). Its function is essential for proper chromosome segregation during [Mitotic metaphase and anaphase](/details-reactome/R-HSA-2555396) and is also involved in [Mitotic spindle assembly](/details-go/GO:0090307) ([Link](https://doi.org/10.1074/jbc.m103364200)). * **DNA Repair and Chromatin Structure:** Beyond cell division, [SMC3](/details-gene/9126) is involved in [Dna repair](/details-go/GO:0006281), a function likely linked to its ability to hold sister chromatids together to facilitate homology-directed repair. Its molecular functions include [Atp binding](/details-go/GO:0005524), [Atp hydrolysis activity](/details-go/GO:0016887), and [Chromatin binding](/details-go/GO:0003682), which are mechanistic requirements for loading cohesin onto DNA and altering chromatin structure ([Link](https://doi.org/10.1038/nature01024)). It is also a known substrate for the ATM and ATR kinases, key regulators of the DNA damage response ([Link](https://doi.org/10.1126/science.1140321)). * **Meiosis and Reproduction:** The gene also plays a specialized role in germline cells, participating in the [Meiotic cell cycle](/details-go/GO:0051321) and [Meiotic synapsis](/details-reactome/R-HSA-1221632), highlighting its conserved importance in both mitotic and meiotic chromosome segregation. ## Research Directions The fundamental role of [SMC3](/details-gene/9126) in cell cycle progression and genome maintenance makes its dysregulation a critical factor in diseases characterized by uncontrolled proliferation, such as cancer. **Proposed Hypotheses:** 1. Given its high expression in hematopoietic progenitors and its role in ensuring proper chromosome segregation, subtle alterations in [SMC3](/details-gene/9126) dosage or function within cells like [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) could be a primary event leading to aneuploidy and subsequent malignant transformation in myeloid leukemias. 2. Because cancer cells often exhibit increased reliance on DNA repair pathways to cope with high replicative stress, targeting [SMC3](/details-gene/9126) may represent a synthetic lethal strategy. Therefore, inhibiting [SMC3](/details-gene/9126) function could selectively sensitize rapidly dividing cancer cells to DNA-damaging agents (e.g., chemotherapy or radiation) while having a lesser effect on quiescent, healthy cells. **Experimental Approach:** To test the second hypothesis, one could utilize a panel of cancer cell lines with high proliferation rates (e.g., leukemia or pancreatic cancer cell lines, consistent with the expression data). [SMC3](/details-gene/9126) expression would be knocked down using shRNA or CRISPRi. These [SMC3](/details-gene/9126)-deficient cells, alongside isogenic controls, would then be treated with sub-lethal doses of a DNA-damaging agent like cisplatin or olaparib. The primary endpoints would be cell viability, measured by colony formation assays, and the extent of DNA damage, assessed by quantifying γH2AX foci. A significant reduction in cell survival and/or a failure to resolve DNA damage in the [SMC3](/details-gene/9126)-deficient cells would support the hypothesis that [SMC3](/details-gene/9126) is a viable target for combination cancer therapies. **Therapeutic Potential:** As a core component of the cell division machinery, [SMC3](/details-gene/9126) presents a challenging but potentially high-impact therapeutic target. Direct targeting could cause significant toxicity in healthy proliferative tissues, such as the intestinal epithelium and bone marrow. However, the principle of cancer cell addiction to specific cell cycle and DNA repair components suggests a possible therapeutic window. The most promising strategy would be **inhibition**, likely through small molecules designed to disrupt its ATPase activity or its interaction with other cohesin subunits. Such an approach would be most applicable to aggressive, highly proliferative cancers and could be particularly effective when used in combination with conventional genotoxic therapies to induce synthetic lethality.

Genular Protein ID: 1801393708

Symbol: SMC3_HUMAN

Name: Structural maintenance of chromosomes protein 3

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 9506951

Title: Complex formation of SMAP/KAP3, a KIF3A/B ATPase motor-associated protein, with a human chromosome-associated polypeptide.

PubMed ID: 9506951

DOI: 10.1074/jbc.273.12.6591

PubMed ID: 14702039

Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.

PubMed ID: 14702039

DOI: 10.1038/ng1285

PubMed ID: 15164054

Title: The DNA sequence and comparative analysis of human chromosome 10.

PubMed ID: 15164054

DOI: 10.1038/nature02462

PubMed ID: 11042152

Title: Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.

PubMed ID: 11042152

DOI: 10.1101/gr.140200

PubMed ID: 18614053

Title: Acetylation of Smc3 by Eco1 is required for S phase sister chromatid cohesion in both human and yeast.

PubMed ID: 18614053

DOI: 10.1016/j.molcel.2008.06.006

PubMed ID: 11076961

Title: Characterization of vertebrate cohesin complexes and their regulation in prophase.

PubMed ID: 11076961

DOI: 10.1083/jcb.151.4.749

PubMed ID: 11590136

Title: A potential role for human cohesin in mitotic spindle aster assembly.

PubMed ID: 11590136

DOI: 10.1074/jbc.m103364200

PubMed ID: 12198550

Title: A chromatin remodelling complex that loads cohesin onto human chromosomes.

PubMed ID: 12198550

DOI: 10.1038/nature01024

PubMed ID: 15656913

Title: Hinderin, a five-domains protein including coiled-coil motifs that binds to SMC3.

PubMed ID: 15656913

DOI: 10.1186/1471-2121-6-3

PubMed ID: 15837422

Title: Sororin, a substrate of the anaphase-promoting complex, is required for sister chromatid cohesion in vertebrates.

PubMed ID: 15837422

DOI: 10.1016/j.molcel.2005.03.017

PubMed ID: 17105772

Title: The DNA helicase ChlR1 is required for sister chromatid cohesion in mammalian cells.

PubMed ID: 17105772

DOI: 10.1242/jcs.03262

PubMed ID: 17525332

Title: ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.

PubMed ID: 17525332

DOI: 10.1126/science.1140321

PubMed ID: 19367720

Title: Phosphorylation analysis of primary human T lymphocytes using sequential IMAC and titanium oxide enrichment.

PubMed ID: 19367720

DOI: 10.1021/pr800500r

PubMed ID: 18691976

Title: Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.

PubMed ID: 18691976

DOI: 10.1016/j.molcel.2008.07.007

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 19907496

Title: Cohesin acetylation speeds the replication fork.

PubMed ID: 19907496

DOI: 10.1038/nature08550

PubMed ID: 19690332

Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

PubMed ID: 19690332

DOI: 10.1126/scisignal.2000007

PubMed ID: 19608861

Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.

PubMed ID: 19608861

DOI: 10.1126/science.1175371

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 22885700

Title: HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle.

PubMed ID: 22885700

DOI: 10.1038/nature11316

PubMed ID: 22628566

Title: In vitro loading of human cohesin on DNA by the human Scc2-Scc4 loader complex.

PubMed ID: 22628566

DOI: 10.1073/pnas.1206840109

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 24275569

Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

PubMed ID: 24275569

DOI: 10.1016/j.jprot.2013.11.014

PubMed ID: 31334757

Title: Cohesin complex-associated holoprosencephaly.

PubMed ID: 31334757

DOI: 10.1093/brain/awz210

PubMed ID: 31452512

Title: Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.

PubMed ID: 31452512

DOI: 10.7554/elife.47362

PubMed ID: 32409525

Title: Cryo-EM structure of the human cohesin-NIPBL-DNA complex.

PubMed ID: 32409525

DOI: 10.1126/science.abb0981

PubMed ID: 17273969

Title: Mutations in cohesin complex members SMC3 and SMC1A cause a mild variant of Cornelia de Lange syndrome with predominant mental retardation.

PubMed ID: 17273969

DOI: 10.1086/511888

PubMed ID: 18996922

Title: Cornelia de Lange syndrome mutations in SMC1A or SMC3 affect binding to DNA.

PubMed ID: 18996922

DOI: 10.1093/hmg/ddn369

Sequence Information:

  • Length: 1217
  • Mass: 141542
  • Checksum: 21EF9A08A5D8096A
  • Sequence:
  • MYIKQVIIQG FRSYRDQTIV DPFSSKHNVI VGRNGSGKSN FFYAIQFVLS DEFSHLRPEQ 
    RLALLHEGTG PRVISAFVEI IFDNSDNRLP IDKEEVSLRR VIGAKKDQYF LDKKMVTKND 
    VMNLLESAGF SRSNPYYIVK QGKINQMATA PDSQRLKLLR EVAGTRVYDE RKEESISLMK 
    ETEGKREKIN ELLKYIEERL HTLEEEKEEL AQYQKWDKMR RALEYTIYNQ ELNETRAKLD 
    ELSAKRETSG EKSRQLRDAQ QDARDKMEDI ERQVRELKTK ISAMKEEKEQ LSAERQEQIK 
    QRTKLELKAK DLQDELAGNS EQRKRLLKER QKLLEKIEEK QKELAETEPK FNSVKEKEER 
    GIARLAQATQ ERTDLYAKQG RGSQFTSKEE RDKWIKKELK SLDQAINDKK RQIAAIHKDL 
    EDTEANKEKN LEQYNKLDQD LNEVKARVEE LDRKYYEVKN KKDELQSERN YLWREENAEQ 
    QALAAKREDL EKKQQLLRAA TGKAILNGID SINKVLDHFR RKGINQHVQN GYHGIVMNNF 
    ECEPAFYTCV EVTAGNRLFY HIVDSDEVST KILMEFNKMN LPGEVTFLPL NKLDVRDTAY 
    PETNDAIPMI SKLRYNPRFD KAFKHVFGKT LICRSMEVST QLARAFTMDC ITLEGDQVSH 
    RGALTGGYYD TRKSRLELQK DVRKAEEELG ELEAKLNENL RRNIERINNE IDQLMNQMQQ 
    IETQQRKFKA SRDSILSEMK MLKEKRQQSE KTFMPKQRSL QSLEASLHAM ESTRESLKAE 
    LGTDLLSQLS LEDQKRVDAL NDEIRQLQQE NRQLLNERIK LEGIITRVET YLNENLRKRL 
    DQVEQELNEL RETEGGTVLT ATTSELEAIN KRVKDTMARS EDLDNSIDKT EAGIKELQKS 
    MERWKNMEKE HMDAINHDTK ELEKMTNRQG MLLKKKEECM KKIRELGSLP QEAFEKYQTL 
    SLKQLFRKLE QCNTELKKYS HVNKKALDQF VNFSEQKEKL IKRQEELDRG YKSIMELMNV 
    LELRKYEAIQ LTFKQVSKNF SEVFQKLVPG GKATLVMKKG DVEGSQSQDE GEGSGESERG 
    SGSQSSVPSV DQFTGVGIRV SFTGKQGEMR EMQQLSGGQK SLVALALIFA IQKCDPAPFY 
    LFDEIDQALD AQHRKAVSDM IMELAVHAQF ITTTFRPELL ESADKFYGVK FRNKVSHIDV 
    ITAEMAKDFV EDDTTHG